Xcout Intel
Progentec Diagnostics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Progentec Diagnostics, Inc. among biotechnology & healthcare companies — ranked by similarity to what Progentec Diagnostics, Inc. actually does, not by market-cap band.
Subscribe to see Progentec Diagnostics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Progentec Diagnostics, Inc.
Progentec Diagnostics, Inc. is a healthcare company based in Oklahoma City, Oklahoma, focused on developing biomarker and digital technologies for the proactive care of autoimmune diseases.
Progentec Diagnostics, Inc. at a glance
Progentec Diagnostics, Inc. is a biotechnology & healthcare company headquartered in United States. It has raised at least $7.5M across the 2 funding rounds on record. Its most recent funding round raised $5M in January 2020. Xcout tracks 5 named people at Progentec Diagnostics, Inc., including Mohan Purushothaman (CEO).
Progentec Diagnostics, Inc. leadership
- Mohan PurushothamanCEO
- Bob SaundersBoard Member
- Hakan SakulBoard Member
- Mary Jo WilliamsonBoard Member
- Mike RohlederBoard Member
Progentec Diagnostics, Inc. funding rounds
At least $7.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $5M | 1 named | |
| SEC Form D filing | $2.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Progentec Diagnostics, Inc. competitors
Ranked by semantic similarity — how close each company is to Progentec Diagnostics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Healthtech
Probably Genetic is a healthcare technology company focused on helping identify rare genetic diseases through genetic testing and clinical software. It serves patients with undiagnosed conditions and the healthcare professionals involved in their diagnosis and care.
Biotechnology
Harmonigenic Corp. is a diagnostics and biotechnology company headquartered in Rochester, New York. The company brings radical innovation to personalized precision medicine, focusing on initial diagnostic and treatment decisions.
Biotechnology
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Medical Diagnostics
i-calQ Corp. develops medical and diagnostic technology products, including cortisol and TSH tests, as well as a mobile app and ProReader. The company provides these diagnostic solutions and products to its customers.
Biotechnology
Exagen Inc. develops and commercializes diagnostic testing solutions, leveraging its proprietary cell-bound complement activation products (CB-CAPs) technology under the AVISE brand throughout the United States. The company's mission is to equip rheumatologists with advanced tools for the precise diagnosis, prognosis, and ongoing management of autoimmune and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its flagship product, AVISE CTD, aids in distinguishing between various connective tissue diseases (CTDs) and other conditions with overlapping symptoms in symptomatic patients. The company's product portfolio includes AVISE Lupus, which assesses complement system activation by measuring B-cell C4d and erythrocyte-bound C4d in blood. AVISE APS offers a comprehensive panel of autoantibody tests for the diagnosis and management of Antiphospholipid Syndrome (APS). For SLE patients, AVISE SLE Prognostic provides an autoantibody panel to evaluate the potential for kidney, brain, and cardiovascular complications. Additionally, AVISE Vasculitis AAV utilizes a testing panel of individual analytes to assist physicians in the assessment and monitoring of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis, while AVISE Anti-CarP helps identify RA patients prone to severe disease, and AVISE PC4d measures platelet-bound C4d. Further offerings include AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, designed to monitor hydroxychloroquine levels. Exagen also holds a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to advance the development of novel patented biomarkers. Incorporated in 2002, the company was formerly known as Exagen Diagnostics, Inc. before rebranding to Exagen Inc. in January 2019. Its headquarters are located in Vista, California.
Biotechnology
Adaptive Biotechnologies Corp. is a biotechnology company headquartered in Seattle, Washington, United States. The firm focuses on decoding and analyzing the human immune system to address various diseases.
Healthcare & Biotechnology
EndoAxis Labs LLC provides an AI-driven platform that helps physicians interpret hormone lab results and diagnose endocrine dysfunctions. The company serves healthcare providers by offering personalized supplement formulations and lifestyle recommendations to support patient hormone health.
Biotechnology
Biological Dynamics, Inc. is a healthcare company committed to improving global health outcomes by detecting diseases in their earliest stages.
Biotech
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
Biotechnology
SomaLogic, Inc. is an active biotechnology company headquartered in Boulder, Colorado, specializing in proteomics technology and biomarker discovery.
Biotechnology
Durin Life Sciences develops Duritect™, a blood-based test that combines autoantibody biomarkers with machine learning technology to assess patients' risk of having Alzheimer's disease or Parkinson's disease. The company provides laboratory analysis services to process these blood samples and deliver risk score reports to physicians and patients.
Biotechnology
TAI Diagnostics, Inc. is a diagnostic laboratory company specializing in specialized genetic panel tests and pathology services within the healthcare sector.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Progentec Diagnostics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Progentec Diagnostics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →